Protalix Biotherapeutics Inc PLX:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/17/21 EDT
1.42quote price arrow up+0.02 (+1.43%)
Volume
20,342
Close
1.40quote price arrow up+0.08 (+6.06%)
Volume
617,476
52 week range
1.30 - 7.02
Loading...
  • Open1.31
  • Day High1.40
  • Day Low1.31
  • Prev Close1.32
  • 52 Week High7.02
  • 52 Week High Date02/10/21
  • 52 Week Low1.30
  • 52 Week Low Date09/16/21

Key Stats

  • Market Cap68.33M
  • Shares Out45.56M
  • 10 Day Average Volume1.69M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • YTD % Change-61.43

KEY STATS

  • Open1.31
  • Day High1.40
  • Day Low1.31
  • Prev Close1.32
  • 52 Week High7.02
  • 52 Week High Date02/10/21
  • 52 Week Low1.30
  • 52 Week Low Date09/16/21
  • Market Cap68.33M
  • Shares Out45.56M
  • 10 Day Average Volume1.69M
  • Dividend-
  • Dividend Yield-
  • Beta2.51
  • YTD % Change-61.43

RATIOS/PROFITABILITY

  • EPS (TTM)-0.16
  • P/E (TTM)-9.03
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Protalix Biotherapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). The Company has developed taliglucerase alfa (marketed under the name Uplyso in Brazil and certain other Latin American countries and Elelyso in the rest of the territories) for the treatment of Gaucher disease that has been approved for marketing in the...
Zeev Bronfeld
Chairman
Dror Bashan
President
Eyal Rubin
Chief Financial Officer
Address
2 Snunit St., Science Park, POB 455
Karmiel
2161401
Israel

Top Peers

SYMBOLLASTCHG%CHG
ENVB
Enveric Biosciences Inc
2.50-0.22-8.09%
CDTX
Cidara Therapeutics Inc
2.13+0.04+1.91%
CNCE
Concert Pharmaceuticals Inc
3.71+0.32+9.44%
ADMA
ADMA Biologics Inc
1.29+0.09+7.50%
SBBP
Strongbridge Biopharma plc
2.12+0.03+1.44%